Korean J Med.
2016 Aug;91(1):12-17. 10.3904/kjm.2016.91.1.12.
The Impact of the SPRINT Trial on Hypertension Guidelines
- Affiliations
-
- 1Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea. skimw@chonnam.ac.kr
- KMID: 2345578
- DOI: http://doi.org/10.3904/kjm.2016.91.1.12
Abstract
- The most recent revision of the blood pressure guidelines adopted less aggressive blood pressure targets, particularly in patients with diabetes and chronic kidney disease, and the elderly. However, the Systolic Blood Pressure Intervention Trial (SPRINT) reported that lowering the systolic blood pressure to <120 mmHg resulted in a decreased risk of cardiovascular disease, compared with lowering the SBP to <140 mmHg, in adults with hypertension but without diabetes. This will likely lead to many changes in clinical practice. Such lowering of systolic blood pressure would benefit some categories of hypertensive patients at an increased risk of cardiovascular disease.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Updated Guideline for Diagnosis of Hypertension in Chronic Kidney Disease Patients: Based on 2017 ACC/AHA Hypertension Guideline
- Ideal Target Blood Pressure in Hypertension
- Management plans for populations with normal-to-hypertensive blood pressures: risks and benefits of antihypertensive drug treatment in populations previously defined as having high-normal blood pressure
- Recent evidence on target blood pressure in patients with hypertension
- Antihypertensive drug therapy: a review based on recent guidelines
